Characterization of T cell immunity in chronic hepatitis B virus-infected mothers with postpartum alanine transaminase flare

[1]  R. Chou,et al.  Efficacy and safety of antiviral prophylaxis during pregnancy to prevent mother-to-child transmission of hepatitis B virus: a systematic review and meta-analysis. , 2020, The Lancet. Infectious diseases.

[2]  Jin-na Li,et al.  Effects of intrauterine exposure to maternal‐derived HBeAg on T cell immunity in cord blood , 2020, Scandinavian journal of immunology.

[3]  Xuesong Gao,et al.  Efficacy and Safety of Lamivudine or Telbivudine in Preventing Mother-to-Child Transmission of Hepatitis B Virus: A Real-World Study , 2020, BioMed research international.

[4]  Yong‐Hong Zhang,et al.  Immune checkpoint molecules in pregnancy: Focus on regulatory T cells , 2020, European journal of immunology.

[5]  C. Coffin,et al.  Hepatitis B and Pregnancy: Virologic and Immunologic Characteristics , 2020, Hepatology communications.

[6]  N. Terrault,et al.  Viral hepatitis and pregnancy. , 1977, Nature reviews. Gastroenterology & hepatology.

[7]  [The guidelines of prevention and treatment for chronic hepatitis B (2019 version)]. , 2019, Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology.

[8]  Songsong Lu,et al.  Increased proportion of functional subpopulations in circulating regulatory T cells in patients with chronic hepatitis B , 2019, Hepatology research : the official journal of the Japan Society of Hepatology.

[9]  S. Belle,et al.  Total Alanine Aminotransferase (ALT) Flares in Pregnant North American Women With Chronic Hepatitis B Infection: Results From a Prospective Observational Study , 2019, The American journal of gastroenterology.

[10]  Feng Chen,et al.  Epidemiological trends and virological traits of hepatitis B virus infection in pregnant women and neonates , 2019, Archives of Virology.

[11]  Yanlin Huang,et al.  Correlations between cytokines produced by T cells and clinical-virological characteristics in untreated chronic hepatitis B patients , 2019, BMC Infectious Diseases.

[12]  Lai Wei,et al.  Management Algorithm for Interrupting Mother to Child Transmission of Hepatitis B Virus. , 2019, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[13]  Mei-Hwei Chang,et al.  The Impact of Universal Infant Hepatitis B Immunization on reducing the Hepatitis B Carrier Rate in Pregnant Women. , 2019, The Journal of infectious diseases.

[14]  J. Lewis,et al.  Incidence, determinants and outcomes of pregnancy‐associated hepatitis B flares: A regional hospital‐based cohort study , 2018, Liver international : official journal of the International Association for the Study of the Liver.

[15]  Noele P. Nelson,et al.  Tenofovir versus Placebo to Prevent Perinatal Transmission of Hepatitis B , 2018, The New England journal of medicine.

[16]  Ming Liu,et al.  The characteristics and predictors of postpartum hepatitis flares in women with chronic hepatitis B , 2018, The American Journal of Gastroenterology.

[17]  Thomas Berg,et al.  EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection. , 2017, Journal of hepatology.

[18]  R. Mohamed,et al.  CD8+ T cells of chronic HCV-infected patients express multiple negative immune checkpoints following stimulation with HCV peptides. , 2017, Cellular immunology.

[19]  M. Nguyen,et al.  Serum Alanine Aminotransferase and Hepatitis B DNA Flares in Pregnant and Postpartum Women with Chronic Hepatitis B , 2016, The American Journal of Gastroenterology.

[20]  Shuqin Zhang,et al.  Tenofovir to Prevent Hepatitis B Transmission in Mothers with High Viral Load. , 2016, The New England journal of medicine.

[21]  B. McMahon,et al.  Antiviral therapy in chronic hepatitis B viral infection during pregnancy: A systematic review and meta‐analysis , 2016, Hepatology.

[22]  X. Liu,et al.  T-cell exhaustion in chronic hepatitis B infection: current knowledge and clinical significance , 2015, Cell Death and Disease.

[23]  S. Lewin,et al.  Clinical and virological predictors of hepatic flares in pregnant women with chronic hepatitis B , 2014, Gut.

[24]  Hua Zhang,et al.  Telbivudine or lamivudine use in late pregnancy safely reduces perinatal transmission of hepatitis B virus in real-life practice , 2014, Hepatology.

[25]  P. Chatterjee,et al.  Regulation of the Anti-Inflammatory Cytokines Interleukin-4 and Interleukin-10 during Pregnancy , 2014, Front. Immunol..

[26]  C. Pan,et al.  Risk of vertical transmission of hepatitis B after amniocentesis in HBs antigen-positive mothers. , 2014, Journal of hepatology.

[27]  Hua Zhang,et al.  Telbivudine or lamivudine use in late pregnancy safely reduces perinatal transmission of hepatitis B virus in real-life practice. , 2014, Hepatology.

[28]  Hong Zhang,et al.  Virologic factors associated with failure to passive–active immunoprophylaxis in infants born to HBsAg‐positive mothers , 2012, Journal of viral hepatitis.

[29]  J. Jönsson,et al.  Systemic Reduction of Functionally Suppressive CD4dimCD25highFoxp3+ Tregs in Human Second Trimester Pregnancy Is Induced by Progesterone and 17β-Estradiol1 , 2009, The Journal of Immunology.

[30]  D. Roelen,et al.  Evidence for a Selective Migration of Fetus-Specific CD4+CD25bright Regulatory T Cells from the Peripheral Blood to the Decidua in Human Pregnancy , 2008, The Journal of Immunology.

[31]  E. Kuipers,et al.  Regulatory T cells contribute to the impaired immune response in patients with chronic hepatitis B virus infection , 2005, Hepatology.

[32]  A. BØyum.  Isolation of Lymphocytes, Granulocytes and Macrophages , 1976 .

[33]  A. Bøyum.  Isolation of lymphocytes, granulocytes and macrophages. , 1976, Scandinavian journal of immunology.

[34]  F. di Nola,et al.  [Viral hepatitis and pregnancy]. , 1967, Minerva medica.